Gastric cancer that metastasizes to the peritoneum, or the lining of the abdominal cavity, has a very poor prognosis and is challenging to treat. Now, a group of researchers has developed mRNA-based vaccines that can target tumor-specific ‘neoantigens.’ In combination with anti-PD1 therapy, these vaccines show high antitumor efficacy against gastric cancer with peritoneal metastasis. This approach can potentially be expanded in order to develop ‘personalized’ cancer vaccines for complicated cancer cases.

Scientists at Tsinghua University have developed a method to grow kidney tumours in the lab using cells from real patients, offering a potential new tool in the fight against renal cancer. Their research, published in the journal Biofabrication, outlines how 3D bioprinting technology can be used to replicate the unique characteristics of each patient’s tumour.

Traditional drug development methods involve identifying a target protin (e.g., a cancer cell receptor) that causes disease, and then searching through countless molecular candidates (potential drugs) that could bind to that protein and block its function. This process is costly, time-consuming, and has a low success rate. KAIST researchers have developed an AI model that, using only information about the target protein, can design optimal drug candidates without any prior molecular data—opening up new possibilities for drug discovery.

Motolani Adedipe, associate professor of Family and Preventive Medicine at the University of Oklahoma Health Sciences Center, has been awarded a Fulbright U.S. Scholar grant under the U.S.–Korea Presidential STEM Initiative to conduct research at Seoul National University Hospital. Her project, “Enhancing Prostate Cancer Survivorship in South Korea: A Mixed Methods, Community‑Engaged Approach,” aims to elevate the quality of life for prostate cancer survivors through community-focused strategies and digital health innovation. 

Researchers at City of Hope published a new study which found that some survivors of childhood cancer are more at risk for serious health issues as they grow older, including new cancers and chronic conditions like heart disease. 

BUFFALO, NY – August 11, 2025 – A new research paper was published in Volume 16 of Oncotarget on July 25, 2025, titled “Dissecting the functional differences and clinical features of R-spondin family members in metastatic prostate cancer.”